QUICK LINKS
MAIN MENU
CONNECT WITH US

Clinical Trial Details

Title
MIT-Es0001-C302: A Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15 mg Estetrol and 3 mg Drospirenone
Study Purpose
In the study we hope to find out how safe and effective this pill is at preventing pregnancy, and what periods are like during the menstrual cycle while taking it. We will also monitor your well-being throughout the study.
Study Plan
The study will last about one year. During this period, participants that meet the study requirements will be asked to take the study pill once a day and to come to the study site at least 7 times for visits.
Investigators

Principal Investigator
Andrew M. Kaunitz, M.D., FACOG
Obstetrics and Gynecology

Resources

News & Announcements

Upcoming Events

May 22

Join the All of Us Research Program

From 8:30 AM until 1:30 PM